MedPath

Recovery Management Intervention in China

Not Applicable
Completed
Conditions
HIV Infections
Methadone
Interventions
Behavioral: Recovery management
Registration Number
NCT01270100
Lead Sponsor
University of California, Los Angeles
Brief Summary

The purpose of the study is to develop and pilot-test a Recovery Management Intervention (RMI) program for heroin addicts released from compulsory rehabilitation in China.

The project has the following specific aims:

Primary aims:

Aim 1. To engage key stakeholders in the local communities involved in supporting the transition of heroin addicts released from compulsory rehabilitation to the community; Aim 2. To identify potential barriers for participating in MMT in China; Aim 3. To develop and deliver educational/training materials on HIV risks, relapse prevention, and MMT; Aim 4. To adapt and develop the Recovery Management Intervention (RMI) program for heroin addicts released from compulsory rehabilitation in China; Aim 5. To conduct a pilot trial and obtain preliminary outcome data associated with RMI, relative to enhanced standard care.

Secondary aim:

Aim 6. To explore predictors of relapse and HIV/AIDS risk behaviors.

It is hypothesized that the intervention will reduce drug use relapse and the negative consequences associated with relapse, including HIV risk behaviors

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

The study population will be drawn from all adult patients at participating compulsory rehabilitation facilities who:

  1. have been incarcerated for at least one year and would have been eligible for MMT at the time of incarceration,
  2. have at least 1 month remaining before release,
  3. met the DSM-IV criteria for heroin dependence at the time of incarceration,
  4. are willing to enroll in methadone maintenance treatment, and
  5. are Shanghai residents who reside in the areas of Shanghai targeted by the study.
Exclusion Criteria

Individuals diagnosed with severe mental illness will not be eligible to participate.

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Recovery management interventionRecovery management-
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Shanghai Mental Health Center

🇨🇳

Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath